{
    "eid": "2-s2.0-85070831943",
    "title": "Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center",
    "cover-date": "2019-07-29",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "bleeding score",
        "von Willebrand disease",
        "von Willebrand factor"
    ],
    "authors": [
        "Chatphatai Moonla",
        "Benjaporn Akkawat",
        "Yaowaree Kittikalayawong",
        "Autcharaporn Sukperm",
        "Mukmanee Meesanun",
        "Noppacharn Uaprasert",
        "Darintr Sosothikul",
        "Ponlapat Rojnuckarin"
    ],
    "citedby-count": 1,
    "ref-count": 41,
    "ref-list": [
        "Hereditary pseudohaemophilia",
        "The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors Organisation haemophilia genetics laboratory network",
        "The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors\u2019 Organization",
        "Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report (USA)",
        "National survey of patients with hemophilia and other congenital bleeding disorders in Thailand",
        "US hemophilia treatment center population trends 1990-2010: patient diagnoses, demographics, health services utilization",
        "Epidemiology of von Willebrand disease in developing countries",
        "Von Willebrand\u2019s disease",
        "Diagnostic approach to von Willebrand disease",
        "A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)",
        "Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease",
        "ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders",
        "Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project",
        "Protein C, protein S and von Willebrand factor levels correlate with bleeding symptoms: a population-based study",
        "Development of a Thai version of the paediatric bleeding assessment tool (Thai paediatric-BAT) suitable for use in children with inherited mucocutaneous bleeding disorders",
        "Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)",
        "Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States",
        "How I treat low von Willebrand factor levels",
        "Von Willebrand factor (VWF) antigen levels and function in healthy Thais",
        "Letter: a method for assaying von Willebrand factor (ristocetin cofactor)",
        "Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor",
        "Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin",
        "Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH",
        "Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin",
        "Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease",
        "Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection",
        "Prospective study of low-dose restocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children",
        "Monitoring of modified factor VIII and IX products",
        "Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH",
        "Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders",
        "The bleeding time as a screening test for evaluation of platelet function",
        "The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology",
        "Von Willebrand disease in Siriraj Hospital: where are we now?",
        "A relatively high frequency of severe (type III) von Willebrand\u2019s disease in Israel",
        "Laboratory diagnosis of congenital von Willebrand disease",
        "Clinical diagnosis of von Willebrand disease",
        "Von Willebrand disease: a clinical and laboratory study of sixty-five patients",
        "Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels",
        "A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor",
        "Type 2N von Willebrand disease: characterization and diagnostic difficulties",
        "Von Willebrand disease and pregnancy: a review of evidence and expert opinion"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}